丹参川芎嗪注射液治疗早期急性脑梗死临床研究

Clinical research of Danshen Chuangxiongqin injection in the treatment of early acute cerebral infarction

目的:探讨丹参川芎嗪注射液治疗早期急性脑梗死的临床疗效。方法:选择2012年3月—2015年11月我院收治的急性脑梗死早期患者110例,随机将其分为两组,各55例。两组患者均采用西医常规治疗,观察组另给予丹参川芎嗪注射液治疗。两组均连续治疗14 d后进行疗效对比。结果:观察组治疗总有效率94.55%明显高于对照组76.36%,差异具有统计学意义(P<0.05);治疗后,观察组CSS评分明显低于对照组,ADL评分明显高于对照组,差异均具有统计学意义(P<0.05)。结论:丹参川芎嗪注射液结合西医方法治疗早期急性脑梗死能明显改善患者的临床症状,治疗效果优于单纯西医治疗。

Objective： To explore the clinical efficacy of Danshen Chuangxiongqin injection in the treatment of early acute cerebral infarction. Methods： 110 patients with acute cerebral infarction admitted to our hospital from March 2012 to November 2015 were randomly divided into two groups, with 55 cases in each group. Both groups received routine western medicine treatment, and the observation group was treated with Danshen Chuangxiongqin injection on the basis of the routine treatment. Two groups were treated for 14 days, and the efficacy was compared. Results： The total effective rate of the observation group was 94.55%, which was significantly higher than that of the control group, 76.36%, and the difference was statistically significant （P 〈 0.05）; after treatment, the CSS score of the observation group was significantly lower than that of the control group, ADL score was significantly higher than that of the control group, the difference was statistically significant （P 〈 0.05）. Conclusion： Danshen Chuangxiongqin injection combined with western medicine could significantly relieve the clinical symptoms of patients in the treatment of early acute cerebral infarction, the treatment effect was better than that of the simple westem medicine treatment.